{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:08:12Z","timestamp":1753877292094,"version":"3.41.2"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,29]]},"abstract":"<jats:p>In a COVID-19 outbreak in a group of 25 twice-vaccinated Israeli travellers, the attack rate was 84%, despite negative preflight polymerase chain reaction tests. This extremely high breakthrough infection rate is attributed mainly to close and prolonged exposures during long bus drives. Masking, distancing and personal responsibility are required to avoid such outbreaks.<\/jats:p>","DOI":"10.1093\/jtm\/taab157","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T10:05:44Z","timestamp":1632823544000},"source":"Crossref","is-referenced-by-count":3,"title":["High attack rate of COVID-19 in an organized tour group of vaccinated travellers to Iceland"],"prefix":"10.1093","volume":"28","author":[{"given":"Shmuel","family":"Benenson","sequence":"first","affiliation":[{"name":"The Faculty of Medicine, Hebrew University of Jerusalem, Israel"},{"name":"Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Ottolenghi","sequence":"additional","affiliation":[{"name":"The Faculty of Medicine, Hebrew University of Jerusalem, Israel"},{"name":"Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matan J","family":"Cohen","sequence":"additional","affiliation":[{"name":"Clalit Health Services, Hebrew University, Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1567-2550","authenticated-orcid":false,"given":"Ran","family":"Nir-Paz","sequence":"additional","affiliation":[{"name":"The Faculty of Medicine, Hebrew University of Jerusalem, Israel"},{"name":"Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1050-1648","authenticated-orcid":false,"given":"Yonatan","family":"Oster","sequence":"additional","affiliation":[{"name":"The Faculty of Medicine, Hebrew University of Jerusalem, Israel"},{"name":"Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"2021122911113624500_ref1","first-page":"CD013717","article-title":"International travel-related control measures to contain the COVID-19 pandemic: a rapid review","volume":"2021","author":"Burns","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122911113624500_ref2","doi-asserted-by":"crossref","first-page":"n2034","DOI":"10.1136\/bmj.n2034","article-title":"Real world effectiveness of covid-19 vaccines","volume":"374","author":"Hungerford","year":"2021","journal-title":"BMJ"},{"key":"2021122911113624500_ref3","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"2021122911113624500_ref4","doi-asserted-by":"crossref","first-page":"taab111","DOI":"10.1093\/jtm\/taab111","article-title":"High attack rate of SARS-CoV-2 infections during a bus tour in Japan","author":"Tsuchihashi","year":"2021","journal-title":"J Travel Med"},{"key":"2021122911113624500_ref5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/oxfordjournals.aje.a113407","article-title":"Influenza virus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age","volume":"116","author":"Fox","year":"1982","journal-title":"Am J Epidemiol"},{"key":"2021122911113624500_ref6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.15585\/mmwr.mm7034e4","article-title":"Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (Delta) variant predominance\u2014eight U.S. locations, December 2020\u2013August 2021","volume":"70","author":"Fowlkes","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021122911113624500_ref7","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months","volume-title":"N Engl J Med","author":"Levin","year":"2021"},{"key":"2021122911113624500_ref8","doi-asserted-by":"crossref","first-page":"e2125394","DOI":"10.1001\/jamanetworkopen.2021.25394","article-title":"Association between exposure characteristics and the risk for COVID-19 infection among health care workers with and without BNT162b2 vaccination","volume":"4","author":"Oster","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2021122911113624500_ref9","doi-asserted-by":"crossref","first-page":"taaa117","DOI":"10.1093\/jtm\/taaa117","article-title":"Absence of in-flight transmission of SARS-CoV-2 likely due to use of face masks on board","volume":"27","author":"Nir-Paz","year":"2020","journal-title":"J Travel Med"},{"key":"2021122911113624500_ref10","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1056\/NEJMp2108567","article-title":"Protecting Olympic participants from Covid-19 - the urgent need for a risk-management approach","volume":"385","author":"Sparrow","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taab157\/40664430\/taab157.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/28\/8\/taab157\/41959305\/taab157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/28\/8\/taab157\/41959305\/taab157.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T12:50:53Z","timestamp":1640782253000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taab157\/6377252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,9,28]]},"published-print":{"date-parts":[[2021,12,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taab157","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"type":"print","value":"1195-1982"},{"type":"electronic","value":"1708-8305"}],"subject":[],"published-other":{"date-parts":[[2021,12]]},"published":{"date-parts":[[2021,9,28]]},"article-number":"taab157"}}